| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/26/1997 | CN1143498A Medicine for eliminating acne and preparing process thereof |
| 02/26/1997 | CN1143497A Method of treating cardiac inflammatory disease |
| 02/26/1997 | CN1143496A Improving tolerability of pharmaceutically active beta-amino acids |
| 02/26/1997 | CN1143495A Ointment for eliminating tinea |
| 02/26/1997 | CN1143494A Composition for resisting skin spots or senility and use thereof |
| 02/26/1997 | CN1034122C Process for preparing antiviral tetrahydroimioazo|1,4¨ benzodiazepin-2-(thi) ones |
| 02/26/1997 | CN1034120C Process for preparing dioxane alkenoic acid derivatives |
| 02/26/1997 | CN1034105C Nasal formulations and process for preparation |
| 02/26/1997 | CA2184052A1 Piperidinylmethyloxazolidinones |
| 02/25/1997 | USRE35465 Method and agents for removing advanced glycosylation endproducts |
| 02/25/1997 | US5606108 Process for preparing anionic polycarbonate and polyester oligomers having useful antiviral properties |
| 02/25/1997 | US5606083 Process for the preparation of taxane derivatives, new derivatives thus obtained and the compositions which contain them |
| 02/25/1997 | US5606065 Antagonist of neurokinin receivers |
| 02/25/1997 | US5606062 Stereoselective reduction |
| 02/25/1997 | US5606060 Topoisomerase II inhibitors and therapeutic uses therefor |
| 02/25/1997 | US5606058 Having reduced side effects |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606041 Process for steroidal peracyl glycosides |
| 02/25/1997 | US5606017 Antitumor agents |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605933 Retinoid conjugate compounds and methods for treating of skin aging |
| 02/25/1997 | US5605931 Protective prostaglandins for use in conjunction with chemotherapeutic agents |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605929 Methods and compositions for inhibiting 5α-reductase activity |
| 02/25/1997 | US5605928 Antiemetic compositions |
| 02/25/1997 | US5605927 Treatment of skin diseases using ginkgolide PAF antagonists |
| 02/25/1997 | US5605926 Trifluoromethyl-containing pseudopeptides active against retroviruses |
| 02/25/1997 | US5605925 1-aminoacetamidopyrroles and 1-amino acetamido-2-(substituted) pyrroles and related compounds |
| 02/25/1997 | US5605924 Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes |
| 02/25/1997 | US5605923 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 02/25/1997 | US5605922 Vision disorders; side effect reduction |
| 02/25/1997 | US5605921 Triazole derivatives and salts thereof, and antifungal agent containing the same |
| 02/25/1997 | US5605919 Prevention of cell injury |
| 02/25/1997 | US5605918 Substituted thiazolidine-2,4-diones |
| 02/25/1997 | US5605917 Method of treating dysmenorrhea employing an interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analog |
| 02/25/1997 | US5605916 Arylalkyl-amines having anticonvulsant and neuroprotective properties |
| 02/25/1997 | US5605910 Bactericides |
| 02/25/1997 | US5605909 Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds |
| 02/25/1997 | US5605907 Useful as a preventive and therapeutic agent for diseases against which a potassium channel opening action is efficacious |
| 02/25/1997 | US5605905 Antitumoral compounds |
| 02/25/1997 | US5605903 Using a hydroxy substituted cyclopentene ring on a heterobicyclic compound |
| 02/25/1997 | US5605902 5-HT2 receptor antagonist compositions useful in treating venous conditions |
| 02/25/1997 | US5605897 Nervous system disorders, psychological disorders |
| 02/25/1997 | US5605895 Cephalosporin antibiotics and processes for preparation thereof |
| 02/25/1997 | US5605894 Compositions for regulating skin wrinkles and/or skin atrophy |
| 02/25/1997 | US5605893 Mixture of carbohydrates, protein and fats |
| 02/25/1997 | US5605892 Improving solubility; light stabilization; adminstering to inhibit fibrin formation following eye surgery |
| 02/25/1997 | US5605891 Administering glycosaminoglycans |
| 02/25/1997 | US5605889 Contains a disintegrant and exhibits no adverse food effect |
| 02/25/1997 | US5605828 Contacting cells with fk-506 rapamycin to inhibit viral replication; immunosuppressants |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605703 Liposomes encapsulating doxorubicin |
| 02/25/1997 | US5605702 Eva-based transdermal matrix system for the administration of an estrogen and/or a progestogen |
| 02/25/1997 | US5605701 A patch containing 3-(3-(hexylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine |
| 02/25/1997 | US5605700 Topical administration of toremifene and its metabolites |
| 02/25/1997 | US5605697 Bifidobacterium growth promotant |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | US5605687 Methods and compositions of a polymer (poloxamer) for repair of electrical injury |
| 02/25/1997 | US5605685 Crosslinked n-vinyl lactam hydrogel and one of pyruvic acid, mono- and polycarboxylated hydrocarbons optionally substituted with hydroxy, and an ammonium or alkali metal salt of the preceding compounds |
| 02/25/1997 | US5605684 Topical thalidomide compositions for surface of mucosal wounds, ulcerations, and lesions |
| 02/25/1997 | CA2183937A1 Alkenyl-benzoylguanidine derivatives |
| 02/25/1997 | CA2127763C Alkaloids from mappia foetida, the use thereof and formulations containing them |
| 02/25/1997 | CA2090509C Process for preparing fibrinogen receptor antagonists |
| 02/25/1997 | CA2085135C Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| 02/25/1997 | CA2049514C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 02/25/1997 | CA2046146C Pyrrole derivatives |
| 02/25/1997 | CA2030396C 5-[1-(imidazol)methyl]-3,3-disubstituted-2(3h)furanone derivatives |
| 02/25/1997 | CA2018978C Preparation of imidazole derivatives for treatment of glaucoma |
| 02/25/1997 | CA2018227C Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity |
| 02/25/1997 | CA1338940C Ó,ó-disubstituted n-cycloalkylalkylbenzylamines, process for their preparation, their use as a medicament and their synthesis intermediates |
| 02/25/1997 | CA1338939C Vinylphenol derivatives, their preparation and their use |
| 02/25/1997 | CA1338937C Process for the manufacture of novel substituted alkanediphosphonic acids |
| 02/25/1997 | CA1338934C 3-aminomethyl derivatives of indane, indoline and ¬dihydro-benzo|-furane and thiophene |
| 02/23/1997 | CA2183804A1 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/20/1997 | WO1997006270A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006254A1 Human mp52 arg protein |
| 02/20/1997 | WO1997006253A1 Method of modulating gene expression with reduced immunostimulatory response |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997006177A1 Process for the preparation of erythromycin derivatives |
| 02/20/1997 | WO1997006174A1 Isomerisation process |
| 02/20/1997 | WO1997006172A1 Novel penam sulfones as beta-lactamase inhibitors |
| 02/20/1997 | WO1997006168A1 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives |
| 02/20/1997 | WO1997006165A1 Aza-anthracyclinone derivatives |
| 02/20/1997 | WO1997006162A1 One pot synthesis of 2-oxazolidinone derivatives |
| 02/20/1997 | WO1997006160A1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
| 02/20/1997 | WO1997006159A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives |
| 02/20/1997 | WO1997006157A1 Dihydropyran derivatives as viral neuraminidase inhibitors |
| 02/20/1997 | WO1997006155A1 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof |
| 02/20/1997 | WO1997006145A1 Fused indan derivatives and salts thereof |
| 02/20/1997 | WO1997006140A1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 02/20/1997 | WO1997006139A1 Inhibitor for narcotic analgetic dependence/resistance acquisition |
| 02/20/1997 | WO1997006138A1 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 02/20/1997 | WO1997006136A1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
| 02/20/1997 | WO1997005900A1 Cell derived antigen presenting vesicles |
| 02/20/1997 | WO1997005898A1 Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer |
| 02/20/1997 | WO1997005896A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
| 02/20/1997 | WO1997005895A1 Treatment of ocular inflammatory conditions with interleukin-10 |